MIRA MIRA PHARMACEUTICALS INC
450
$0.655
$0.0245
(3.61%)
| Watchers | 450 |
| 52-Wk Low | $0.6309 |
| 52-Wk High | $7.98 |
| Market Cap | $9.68M |
| Volume | 76,819.00 |
| 52-Wk High | $7.98 |
| 52-Wk Low | $0.6309 |
Mira Pharmaceuticals Announces Encouraging Preclinical Results Advancing Ketamir-2 Towards Potential Year-End IND SubmissionPR Newswire • about 2 months ago
Mira Pharmaceuticals Announces Encouraging Preclinical Results Advancing Ketamir-2 Towards Potential Year-End IND Submission Mira Pharmaceuticals Announces Encouraging Preclinical Results Advancing...
Share to Feed
MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former Head of Pharmacology at Synthelabo, as Chief Scientific Advisor MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former Head of Pharmacology at...
MIRA Pharmaceuticals' revelation on MIRA1a. Uncover MIRA-55, a potent oral marijuana drug candidate for anxiety and cognitive decline.
read more...
Gagnants
Le titre Psyence Biomedical (NASDAQ:PBM) a grimp vendredi de 146,36% 3,13 dollars lors de la session ordinaire.
L'action Ainos (NASDAQ:AIMD) a grimp de 88,36% 2,11 dollars.
Le titre...
MIRA Pharmaceuticals Provides Corporate Update MIRA Pharmaceuticals Provides Corporate Update PR Newswire BALTIMORE, Feb. 5, 2024 Announces Research Collaboration with Pharmaseed to Conduct...
Shares of MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA Get Free Report) dropped 4.4% during mid-day trading on Wednesday . The stock traded as low as $0.86 and last traded at $0.87. Approximately...